Gonzalez Brian D, Jim Heather S L, Cessna Julie M, Small Brent J, Sutton Steven K, Jacobsen Paul B
Health Outcomes and Behavior Program, Moffitt Cancer Center, Tampa, FL, USA.
Department of Psychology, University of South Florida, Tampa, FL, USA.
Psychooncology. 2015 Dec;24(12):1774-83. doi: 10.1002/pon.3793. Epub 2015 Mar 9.
Lung cancer has a commonly understood behavioral etiology. Thus, lung cancer patients are often blamed for their illness and may seek to avoid this blame by concealing their diagnosis from others. This study sought to determine the prevalence of concealment and identify demographic, clinical, and psychosocial correlates of concealment among lung cancer patients.
A sample of 117 lung cancer patients receiving chemotherapy for non-small cell or small cell lung cancer was recruited and completed self-report demographic questionnaires, a measure of diagnosis concealment designed and pilot tested for this study, and standard measures of psychosocial variables. Clinical factors were assessed via a medical chart review.
Thirty participants (26%) reported concealing their diagnosis in the previous month, most frequently from casual friends and close friends. Reported reasons for concealment largely reflected concern for others. Univariate analyses indicated that those who concealed their lung cancer diagnosis reported more internalized shame related to their illness and use of positive reappraisal as a coping strategy (ps ≤ 0.02). In addition, those who concealed were more likely to have used alcohol in the previous month and have a more recent recurrence, among those who had a recurrence (ps ≤ 0.04). Multivariate analyses indicated that internalized shame and use of positive reappraisal accounted for significant unique variance in concealment above and beyond that accounted for by use of alcohol (ps < 0.05).
Future research should aim to replicate and extend these findings with longitudinal designs to elucidate the directionality of the associations observed in this study.
肺癌具有普遍为人所理解的行为病因。因此,肺癌患者常因自身疾病而受到指责,他们可能试图通过向他人隐瞒诊断来避免这种指责。本研究旨在确定隐瞒行为的发生率,并识别肺癌患者中隐瞒行为的人口统计学、临床和心理社会相关因素。
招募了117名接受非小细胞肺癌或小细胞肺癌化疗的肺癌患者样本,他们完成了自我报告的人口统计学问卷、为本研究设计并进行了预试验的诊断隐瞒测量量表,以及心理社会变量的标准测量量表。通过病历审查评估临床因素。
30名参与者(26%)报告在前一个月隐瞒了自己的诊断,最常隐瞒的对象是普通朋友和亲密朋友。报告的隐瞒原因主要反映了对他人的担忧。单因素分析表明,隐瞒肺癌诊断的患者报告了更多与疾病相关的内化羞耻感,并将积极重新评价作为一种应对策略(p值≤0.02)。此外,在有复发情况的患者中,隐瞒诊断的患者在前一个月更有可能饮酒,且复发时间更近(p值≤0.04)。多因素分析表明,内化羞耻感和积极重新评价的使用在隐瞒行为中占显著的独特变异,超出了饮酒所导致的变异(p值<0.05)。
未来的研究应以纵向设计来复制和扩展这些发现,以阐明本研究中观察到的关联的方向性。